Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by pierre013on Feb 15, 2015 4:22pm
477 Views
Post# 23432180

RE:1 year

RE:1 yearLike I said in an other post, don't wish a takeover. The core shareholders of Prometic know a lot more than us about the real value of Prometic. We are just at the beginning and would not be surprised to see PLI at 100 dollars between 2020 and 2022. So a 20 dollars bid would be cheap shot. If we want to really get rich, PLI has to go by itself for the next 10 to 20 years.In the 80's, Biochem Pharma went from 1 to 35 dollars in a matter of time. I see PLI like CGI that will grow exponential over the next 10 years. It's the stock of a lifetime. So we have to be very patient to get the real value of this stock. GLTA
Bullboard Posts